Certara, Inc. (CERT) Presents At Baird Global Healthcare Conference 2025 (Transcript)

Company Overview - Certara is a leader in biosimulation software and services, focusing on revolutionizing drug discovery and development [1] - The company went public in 2020 and currently employs approximately 1,500 people globally [2] - Certara's services or software can be traced to 90% of all new drugs approved in the last decade, highlighting its significant impact on the pharmaceutical industry [3] Financial Performance - Certara is a profitable company with an EBITDA margin in the 30s [3] - The company's revenue is roughly split between software and services, with a 50% contribution from each segment [3] Industry Context - The drug development process is facing challenges, with nearly 90% of new medicines failing in interclinical trials, indicating a need for a new model in drug development [4]